Navigation Links
Bunge Responds to Syngenta Suit
Date:8/23/2011

ST. LOUIS, Aug. 23, 2011 /PRNewswire/ -- Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), issued the following statement which can be attributed to Soren Schroder, Bunge North America president and CEO.

"Bunge North America is aware from press reports of Syngenta's allegations.  From what we know and from prior conversations with Syngenta, we are surprised and disappointed that Syngenta has taken an action which could put at risk a major export market for U.S. corn producers -- China.

Bunge is a strong proponent of agricultural biotechnology and the benefits it offers to the entire value chain.  We have communicated to Syngenta on several occasions that Bunge looks forward to accepting Agrisure® Viptera™ once approval from China is secured.  We understand that Syngenta expects this will happen in early 2012.

However, until this approval occurs, we must protect the integrity of our export supply chain by not accepting Agrisure Viptera and other varieties that do not have major export market approval.  Our obligation to our farmer customers is to provide access to the global marketplace and the price benefits of that access.  Syngenta's decision to commercialize Agrisure Viptera should not foreclose our ability to sell to a major market – China.

Bunge's decision not to accept Agrisure Viptera is consistent with the North American Export Grain Association's (NAEGA) policy to advocate that technology providers receive all major international approvals for a trait prior to seed sales.  The grain export industry, which includes Bunge, notified Syngenta more than a year ago that China is considered a major export market.

According to the U.S. Department of Agriculture, China is currently the seventh largest destination for U.S. corn with imports expected to gro
'/>"/>

SOURCE Bunge North America
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SG Biofuels and Bunge Form Strategic Alliance to Process Jatropha Seeds Into Sustainable Crude Oil
2. Bunge Limited to Expand Sugar and Bioenergy Business in Brazil
3. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
4. HCCS Responds to Recent Tornados, Earthquakes and Flooding With Free Online Training Course for Disaster Preparedness
5. Virtual reality helps researchers track how brain responds to surroundings
6. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
7. China Biologic Products Responds to Allegations on Financial Websites
8. Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification
9. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
10. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
11. Immucor Responds To FDA Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... , July 24, 2015  Champions Oncology (OTC-BB: ... technology solutions and services to personalize the development and ... its financial and operational results for the fourth quarter ... Tuesday, July 28, 2015, before market open. ... the results that day at 9:00 a.m. EDT (6:00 ...
(Date:7/24/2015)... July 24, 2015 , Adds ... , Expands product offering for chronic kidney disease and ... in diabetes-related complications and dermatology , Increases group ... ("3SBio" or ,the Company"), a leading China ... and marketing biopharmaceutical products, today announced that it has ...
(Date:7/23/2015)... ... , ... Science and technology continue to improve all aspects of brain tumor ... to Susan Chang, MD, director of the Division of Neuro-oncology at UC San Francisco. ... impacting the development of new treatments and advancing strategies to minimize treatment side effects ...
(Date:7/23/2015)... ... 2015 , ... The Pittcon 2016 Program Committee is extremely pleased to announce ... Professor, by courtesy, of Applied Physics at Stanford University, will present the Wallace ... Nanoscopy in Cells and Beyond” , Dr. Moerner’s lecture will focus on his ...
Breaking Biology Technology:Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 23SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3The 2014 Nobel Prize in Chemistry Recipient W. E. Moerner, to Deliver Wallace H. Coulter Lecture at Pittcon 2016 2The 2014 Nobel Prize in Chemistry Recipient W. E. Moerner, to Deliver Wallace H. Coulter Lecture at Pittcon 2016 3
... Corporation (NYSE: KMB ) today announced ... Global Nonwovens, has been named to Savoy Magazine,s ... The Top 100 listing showcases a cross section ... a diverse range of industries who demonstrate leadership and ...
... engineer Robert J. Wood has been named one of ... T. Waterman Award. Wood, an Associate Professor of ... Applied Sciences (SEAS) and a Core Member of the ... the honor with Scott Aaronson of the Massachusetts Institute ...
... 2012  On the occasion of World Kidney Day, Kibow ... from an expanded clinical trial of Renadyl™ ( http://www.Renadyl.com ... quality of life (QOL) previously established in a pilot-scale ... in the product formulation are "Generally Recognized As Safe" ...
Cached Biology Technology:Kimberly-Clark's Bob Stargel Named One of Savoy Magazine's Top 100 Most Influential Blacks in Corporate America 2Kimberly-Clark's Bob Stargel Named One of Savoy Magazine's Top 100 Most Influential Blacks in Corporate America 3Engineer Robert J. Wood to receive NSF's Alan T. Waterman Award 2Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function 2Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function 3
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... Established to encourage dedication to science, originality and ... and Beverly Sackler Prize in the Physical Sciences was ... of Wisconsin-Madison for pioneering new fields and developing research ... Prof. Gregory D. Scholes of Toronto University for his ...
... Sutro Biopharma, a biopharmaceutical company developing novel and ... announced that a study published in the July ... that the company,s biochemical protein synthesis technology platform ... with straightforward downstream purification processes. In ...
... of Iowa Roy J. and Lucille A. Carver College ... create a double source of inflammation in the lungs. ... 27 edition of the Journal of Biological Chemistry. ... was lead author of the paper, "Induction of Inflammasome ...
Cached Biology News:Tel Aviv University's Sackler Prizes awarded to 2 North American chemists 2Study Shows Sutro Biopharma's Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals 2Carbon black nanoparticles can cause cell death 2
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... Sections are large (3-5mm in diameter) in ...
... The DNA Engine Opticon real-time PCR ... LEDs for fluorescence excitation (450-495 nm) and ... nm). The Opticon system is built on ... includes a thermal gradient feature. This item ...
... Precision-designed for Optimal Microdissection , CapSure HS ... precise and rapid extraction of populations of ... samples with Laser Capture Microdissection., Ensure ... Molecular Analysis , All CapSure LCM Caps ...
... VersArray ChipReader systems are highly sensitive ... of microarrays. These are advanced scanners that ... response and background level, and optimizing the ... the top end of the range for ...
Biology Products: